<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04016597</url>
  </required_header>
  <id_info>
    <org_study_id>2019-00226</org_study_id>
    <nct_id>NCT04016597</nct_id>
  </id_info>
  <brief_title>Nitric Oxide Lung Diffusing Capacity in Healthy, Non-smoking Adults</brief_title>
  <official_title>Comparison of Two Commercially Available Devices to Measure Nitric Oxide Lung Diffusing Capacity in Healthy, Non-smoking Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The measurement of nitric oxide lung diffusing capacity (DLNO) has been recently&#xD;
      standardised. To date, two pulmonary function devices are commercially available and are used&#xD;
      for the measurement of DLNO. No previous study assessed differences in gas exchange outcomes&#xD;
      (e.g., DLNO values) between both devices.&#xD;
&#xD;
      The aim of this project is to compare two commercially available devices that measure lung&#xD;
      diffusing capacity for nitric oxide (DLNO).&#xD;
&#xD;
        1. &quot;MasterScreenTM&quot; (PFT Pro, Jaeger, CareFusion, Hoechberg, Germany&#xD;
&#xD;
        2. &quot;HypAir&quot; (&quot;HA&quot;, Medisoft, Dinant, Belgium).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In a single-center, crossover study conducted at the University Hospital Zurich, Switzerland,&#xD;
      35 healthy, non-smoking adults (&gt;=18 years) will be invited to perform DLNO measurements in&#xD;
      random order using the MasterScreenTM (PFT Pro, Jaeger, CareFusion, Hoechberg, Germany) and&#xD;
      HypAir (Medisoft, Dinant, Belgium) devices during one study visit.&#xD;
&#xD;
      The order of the tests on the MasterscreenTM and HypAir devices will be randomly allocated&#xD;
      using central randomisation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2019</start_date>
  <completion_date type="Actual">January 31, 2020</completion_date>
  <primary_completion_date type="Actual">January 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in nitric oxide lung diffusing capacity (mL/min/mmHg)</measure>
    <time_frame>1 hour</time_frame>
    <description>Single-breath measurements with MasterScreenTM (PFT Pro, Jaeger, CareFusion, Hoechberg, Germany) and HypAir (Medisoft, Dinant, Belgium).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Difference in carbon monoxide lung diffusing capacity (mL/min/mmHg)</measure>
    <time_frame>1 hour</time_frame>
    <description>Single-breath measurements with MasterScreenTM (PFT Pro, Jaeger, CareFusion, Hoechberg, Germany) and HypAir (Medisoft, Dinant, Belgium).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in Alveolar volume (L)</measure>
    <time_frame>1 hour</time_frame>
    <description>Single-breath measurements with MasterScreenTM (PFT Pro, Jaeger, CareFusion, Hoechberg, Germany) and HypAir (Medisoft, Dinant, Belgium).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in inspiratory volume (L)</measure>
    <time_frame>1 hour</time_frame>
    <description>Single-breath measurements with MasterScreenTM (PFT Pro, Jaeger, CareFusion, Hoechberg, Germany) and HypAir (Medisoft, Dinant, Belgium).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in breath-hold time (s)</measure>
    <time_frame>1 hour</time_frame>
    <description>Single-breath measurements with MasterScreenTM (PFT Pro, Jaeger, CareFusion, Hoechberg, Germany) and HypAir (Medisoft, Dinant, Belgium).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in inspired concentrations for nitric oxide (in %)</measure>
    <time_frame>1 hour</time_frame>
    <description>Single-breath measurements with MasterScreenTM (PFT Pro, Jaeger, CareFusion, Hoechberg, Germany) and HypAir (Medisoft, Dinant, Belgium).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in expired concentrations for nitric oxide (in %)</measure>
    <time_frame>1 hour</time_frame>
    <description>Single-breath measurements with MasterScreenTM (PFT Pro, Jaeger, CareFusion, Hoechberg, Germany) and HypAir (Medisoft, Dinant, Belgium).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in inspired concentrations for carbon monoxide (in %)</measure>
    <time_frame>1 hour</time_frame>
    <description>Single-breath measurements with MasterScreenTM (PFT Pro, Jaeger, CareFusion, Hoechberg, Germany) and HypAir (Medisoft, Dinant, Belgium).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in expired concentrations for carbon monoxide (in %)</measure>
    <time_frame>1 hour</time_frame>
    <description>Single-breath measurements with MasterScreenTM (PFT Pro, Jaeger, CareFusion, Hoechberg, Germany) and HypAir (Medisoft, Dinant, Belgium).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in inspired concentrations for helium (%)</measure>
    <time_frame>1 hour</time_frame>
    <description>Single-breath measurements with MasterScreenTM (PFT Pro, Jaeger, CareFusion, Hoechberg, Germany) and HypAir (Medisoft, Dinant, Belgium).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in expired concentrations for helium (%)</measure>
    <time_frame>1 day</time_frame>
    <description>Single-breath measurements with MasterScreenTM (PFT Pro, Jaeger, CareFusion, Hoechberg, Germany) and HypAir (Medisoft, Dinant, Belgium).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in inspired concentrations for oxygen (%)</measure>
    <time_frame>1 hour</time_frame>
    <description>Single-breath measurements with MasterScreenTM (PFT Pro, Jaeger, CareFusion, Hoechberg, Germany) and HypAir (Medisoft, Dinant, Belgium).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in expired concentrations for oxygen (%)</measure>
    <time_frame>1 hour</time_frame>
    <description>Single-breath measurements with MasterScreenTM (PFT Pro, Jaeger, CareFusion, Hoechberg, Germany) and HypAir (Medisoft, Dinant, Belgium).</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">35</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Lung diffusing capacity measurements</arm_group_label>
    <description>Participants perform single-breath lung diffusing capacity measurements in random order during one study visit.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Jaeger Masterscreen TM</intervention_name>
    <description>Single-breath nitric oxide lung diffusing capacity</description>
    <arm_group_label>Lung diffusing capacity measurements</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HypAir Medisoft</intervention_name>
    <description>Single-breath nitric oxide lung diffusing capacity</description>
    <arm_group_label>Lung diffusing capacity measurements</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy people&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - Age 18 years and older&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous thoracic surgery&#xD;
&#xD;
          -  Smoking&#xD;
&#xD;
          -  Chronic lung disease (e.g., asthma bronchiale, COPD)&#xD;
&#xD;
          -  Forced expiratory volume in 1s and/or forced vital capacity below the lower limit of&#xD;
             normal based on spirometry [Quanjer et al. Eur Respir J 2005]&#xD;
&#xD;
          -  Current respiratory infection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Radtke, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Zurich, EBPI, Switzerland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Zurich and University Hospital of Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>8001</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <results_reference>
    <citation>Zavorsky GS, Hsia CC, Hughes JM, Borland CD, Gu√©nard H, van der Lee I, Steenbruggen I, Naeije R, Cao J, Dinh-Xuan AT. Standardisation and application of the single-breath determination of nitric oxide uptake in the lung. Eur Respir J. 2017 Feb 8;49(2). pii: 1600962. doi: 10.1183/13993003.00962-2016. Print 2017 Feb.</citation>
    <PMID>28179436</PMID>
  </results_reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>July 4, 2019</study_first_submitted>
  <study_first_submitted_qc>July 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 11, 2019</study_first_posted>
  <last_update_submitted>February 10, 2020</last_update_submitted>
  <last_update_submitted_qc>February 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>diffusing capacity</keyword>
  <keyword>reliability</keyword>
  <keyword>healthy</keyword>
  <keyword>adults</keyword>
  <keyword>nitric oxide</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

